definiens: shall mean all of [COMPANY] 's interests in and to ( a ) the Ligand Technology and Program Technology as those terms are defined in the Ligand Agreement ( including without limitation, the Ligand patents and patent applications listed on Exhibit B-2 ), ( b ) the Cytochroma Technology and Collaboration Technology as those terms are defined in the Cytochroma Agreement ( including without limitation, the Cytochroma patents and patent applications listed on Exhibit B-3 ), ( c ) the Patent Rights, University Improvements, University Materials and University knowledge, know - how and/or techniques as those terms are defined in the UWO License Agreement ( including without limitation, the UWO patents and patent applications listed on Exhibit B-4 ), and ( d ) any Inventions licensed to A llergan by the Peter MacCallum Cancer Institute if and only if [COMPANY] exercises its option rights under the PMCI Agreement